Omics! Omics! blogger Keith Robison is eyeing Veridex's RT-PCR test for breast cancer metastases with interest since it could avoid the time lapse between screening and follow-up testing. "If this holds true, then this is an example of molecular diagnostics really having a big impact in a major health problem," he writes.
Jul 18, 2007